Saito Pharmaceutical shines at the 23rd World Pharmaceutical Raw Materials China Exhibition, accelerating global market expansion

On June 24, the 23rd World Pharmaceutical Raw Materials China Exhibition (CPHI China 2025) was grandly held at the Shanghai New International Expo Center. More than 3,500 elites and leaders in the global pharmaceutical industry gathered together to showcase the latest technological achievements, explore new opportunities in the pharmaceutical industry, and jointly write a new chapter of internationalization and sustainable development. In this grand event, Sheng Ao Pharmaceutical, with its excellent green and sustainable packaging technology, became one of the focuses of the exhibition.

Sheng Ao Pharmaceutical participated in this grand event and showcased its new plastic bottle veterinary drug packaging products, attracting widespread attention from global merchants. The booth (E3B22) was bustling with visitors, with a constant stream of new and old customers coming to inquire and visit. This not only consolidated existing cooperative relationships but also attracted a large number of new cooperative customers, laying a solid foundation for market development and injecting new impetus into the green and sustainable development of the pharmaceutical industry.

Sheng Ao Pharmaceutical showcased products such as blow-fill-seal plastic bottle powder injections and BFS blow-fill-seal plastic bottle water injections, demonstrating its plastic bottle veterinary drug packaging technology. Each product reflects Sheng Ao Pharmaceutical's deep understanding and unique innovation in safety and efficacy, environmental protection, and ease of use. Sheng Ao Pharmaceutical is committed to using excellent products and technological strength to help create safer and more efficient aseptic dispensing solutions, promoting green and environmental transformation and sustainable strategic development.

On the first day of the exhibition, Sheng Ao Pharmaceutical's sales team actively communicated with customers from international markets such as North America, South America, Europe, Japan, South Korea, India, and Southeast Asia, as well as many end-users and distributors. They conducted extensive and in-depth exchanges on key product information, market prices, and industry trends. This not only brought Sheng Ao Pharmaceutical more high-quality sales channels but also further strengthened its cooperative relationships with customers.

At this exhibition, Sheng Ao Pharmaceutical not only showcased its technological strength and product advantages but also provided a platform for communication and cooperation. Sheng Ao sales personnel always communicated with participants with enthusiasm and patience. The characteristics and advantages of the products were vividly demonstrated through their wonderful speeches and presentations, and good cooperative relationships were established with many peers. Through exchanges and discussions with peers, Sheng Ao Pharmaceutical further understood market demand and industry trends, providing valuable references for future product research and development and market expansion.

At this exhibition, Sheng Ao Pharmaceutical not only used this industry platform to showcase its strength in the injectable veterinary drug field but also obtained many industry trends through networking with peers and further deepened its connection with the international market, laying a solid foundation for Sheng Ao Pharmaceutical's internationalization process. In the future, Sheng Ao Pharmaceutical will continue to promote the internationalization of product market development and contribute more to the development of the global pharmaceutical industry.